Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 173

1.

Screening of Luzula species native to the Carpathian Basin for anti-inflammatory activity and bioactivity-guided isolation of compounds from Luzula luzuloides (Lam.) Dandy & Wilmott.

Tóth B, Chang FR, Hwang TL, Szappanos Á, Mándi A, Hunyadi A, Kurtán T, Jakab G, Hohmann J, Vasas A.

Fitoterapia. 2017 Jan;116:131-138. doi: 10.1016/j.fitote.2016.12.004.

PMID:
27940118
2.

Environmental Factors Correlated with the Metabolite Profile of Vitis vinifera cv. Pinot Noir Berry Skins along a European Latitudinal Gradient.

Del-Castillo-Alonso MÁ, Castagna A, Csepregi K, Hideg É, Jakab G, Jansen MA, Jug T, Llorens L, Mátai A, Martínez-Lüscher J, Monforte L, Neugart S, Olejnickova J, Ranieri A, Schödl-Hummel K, Schreiner M, Soriano G, Teszlák P, Tittmann S, Urban O, Verdaguer D, Zipoli G, Martínez-Abaigar J, Núñez-Olivera E.

J Agric Food Chem. 2016 Nov 23;64(46):8722-8734.

PMID:
27794599
3.

Antibacterial screening of Juncaceae species native to the Carpathian Basin against resistant strains and LC-MS investigation of phenanthrenes responsible for the effect.

Tóth B, Liktor-Busa E, Urbán E, Csorba A, Jakab G, Hohmann J, Vasas A.

Fitoterapia. 2016 Dec;115:69-73. doi: 10.1016/j.fitote.2016.09.024.

PMID:
27702667
4.

The 11-year long-term follow-up study from the randomized BENEFIT CIS trial.

Kappos L, Edan G, Freedman MS, Montalbán X, Hartung HP, Hemmer B, Fox EJ, Barkhof F, Schippling S, Schulze A, Pleimes D, Pohl C, Sandbrink R, Suarez G, Wicklein EM; BENEFIT Study Group..

Neurology. 2016 Sep 6;87(10):978-87. doi: 10.1212/WNL.0000000000003078.

5.

Emergence and interhospital spread of OXA-48-producing Klebsiella pneumoniae ST395 clone in Western Hungary.

Kovács K, Nyul A, Mestyán G, Melegh S, Fenyvesi H, Jakab G, Szabó H, Jánvári L, Damjanova I, Tóth Á.

Infect Dis (Lond). 2017 Mar;49(3):231-233. doi: 10.1080/23744235.2016.1207252. No abstract available.

PMID:
27465499
6.

The effects of fatigue, depression and the level of disability on the health-related quality of life of glatiramer acetate-treated relapsing-remitting patients with multiple sclerosis in Hungary.

Fricska-Nagy Z, Füvesi J, Rózsa C, Komoly S, Jakab G, Csépány T, Jobbágy Z, Lencsés G, Vécsei L, Bencsik K.

Mult Scler Relat Disord. 2016 May;7:26-32. doi: 10.1016/j.msard.2016.02.006.

PMID:
27237753
7.

Oral fingolimod in primary progressive multiple sclerosis (INFORMS): a phase 3, randomised, double-blind, placebo-controlled trial.

Lublin F, Miller DH, Freedman MS, Cree BA, Wolinsky JS, Weiner H, Lubetzki C, Hartung HP, Montalban X, Uitdehaag BM, Merschhemke M, Li B, Putzki N, Liu FC, Häring DA, Kappos L; INFORMS study investigators..

Lancet. 2016 Mar 12;387(10023):1075-84. doi: 10.1016/S0140-6736(15)01314-8.

PMID:
26827074
8.

Protein and alkaloid patterns of the floral nectar in some solanaceous species.

Kerchner A, Darók J, Bacskay I, Felinger A, Jakab G, Farkas Á.

Acta Biol Hung. 2015 Sep;66(3):304-15. doi: 10.1556/018.66.2015.3.6.

PMID:
26344026
9.

Iterative Coupling of Two Different Enones by Nitromethane Using Bifunctional Thiourea Organocatalysts. Stereocontrolled Assembly of Cyclic and Acyclic Structures.

Varga S, Jakab G, Csámpai A, Soós T.

J Org Chem. 2015 Sep 18;80(18):8990-6. doi: 10.1021/acs.joc.5b01474.

PMID:
26301563
10.

Experiences with PMMA cement as a stand-alone intervertebral spacer: Percutaneous cement discoplasty in the case of vacuum phenomenon within lumbar intervertebral discs.

Varga PP, Jakab G, Bors IB, Lazary A, Szövérfi Z.

Orthopade. 2015 Nov;44 Suppl 1:S1-7. doi: 10.1007/s00132-014-3060-1.

PMID:
25875227
11.

Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Homma S, Thompson JL, Qian M, Ye S, Di Tullio MR, Lip GY, Mann DL, Sacco RL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Graham S, Mohr JP, Labovitz AJ, Buchsbaum R, Estol CJ, Lok DJ, Ponikowski P, Anker SD; WARCEF Investigators..

Circ Heart Fail. 2015 May;8(3):504-9. doi: 10.1161/CIRCHEARTFAILURE.114.001725.

12.

[Experiences with PMMA cement as a stand-alone intervertebral spacer. Percutaneous cement discoplasty in the case of vacuum phenomenon within lumbar intervertebral discs].

Varga PP, Jakab G, Bors IB, Lazary A, Szövérfi Z.

Orthopade. 2015 Feb;44(2):124-31. doi: 10.1007/s00132-015-3092-1. German.

PMID:
25715774
13.

Xanthine oxidase inhibitory activity of extracts prepared from Polygonaceae species.

Orbán-Gyapai O, Lajter I, Hohmann J, Jakab G, Vasas A.

Phytother Res. 2015 Mar;29(3):459-65. doi: 10.1002/ptr.5275.

PMID:
25510560
14.

Cognitive function in ambulatory patients with systolic heart failure: insights from the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Graham S, Ye S, Qian M, Sanford AR, Di Tullio MR, Sacco RL, Mann DL, Levin B, Pullicino PM, Freudenberger RS, Teerlink JR, Mohr JP, Labovitz AJ, Lip GY, Estol CJ, Lok DJ, Ponikowski P, Anker SD, Thompson JL, Homma S; WARCEF Investigators..

PLoS One. 2014 Nov 26;9(11):e113447. doi: 10.1371/journal.pone.0113447.

15.

Recurrent stroke in the warfarin versus aspirin in reduced cardiac ejection fraction (WARCEF) trial.

Pullicino PM, Qian M, Sacco RL, Freudenberger R, Graham S, Teerlink JR, Mann D, Di Tullio MR, Ponikowski P, Lok DJ, Anker SD, Lip GY, Estol CJ, Levin B, Mohr JP, Thompson JL, Homma S; WARCEF Investigators..

Cerebrovasc Dis. 2014;38(3):176-81. doi: 10.1159/000365502.

16.

Automated body-lung-air material map segmentation from pre-clinical MRI images for PET attenuation correction in Tera-Tomo 3D PET reconstruction engine of nanoScan PET/MRI system.

Bandi P, Jakab G, Zsoter N, Mathe D, Nemeth G, Nagy K, Hobor S, Papp L.

EJNMMI Phys. 2014 Jul;1(Suppl 1):A86. doi: 10.1186/2197-7364-1-S1-A86. No abstract available.

17.

Inhibition of G protein-activated inwardly rectifying K+ channels by extracts of Polygonum persicaria and isolation of new flavonoids from the chloroform extract of the herb.

Lajter I, Vasas A, Orvos P, Bánsághi S, Tálosi L, Jakab G, Béni Z, Háda V, Forgo P, Hohmann J.

Planta Med. 2013 Dec;79(18):1736-41. doi: 10.1055/s-0033-1351016.

PMID:
24218371
18.

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage.

Filippi M, Rocca MA, Pagani E, De Stefano N, Jeffery D, Kappos L, Montalban X, Boyko AN, Comi G; ALLEGRO Study Group..

J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):851-8. doi: 10.1136/jnnp-2013-306132.

PMID:
24029546
19.

How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?

Fazekas F, Bajenaru O, Berger T, Fabjan TH, Ledinek AH, Jakab G, Komoly S, Kobys T, Kraus J, Kurča E, Kyriakides T, Lisý L, Milanov I, Nehrych T, Moskovko S, Panayiotou P, Jazbec SŠ, Sokolova L, Taláb R, Traykov L, Turčáni P, Vass K, Vella N, Voloshyná N, Havrdová E.

Front Neurol. 2013 May 1;4:10. doi: 10.3389/fneur.2013.00010.

20.

Rivaroxaban for thromboprophylaxis in acutely ill medical patients.

Cohen AT, Spiro TE, Büller HR, Haskell L, Hu D, Hull R, Mebazaa A, Merli G, Schellong S, Spyropoulos AC, Tapson V; MAGELLAN Investigators..

N Engl J Med. 2013 Feb 7;368(6):513-23. doi: 10.1056/NEJMoa1111096.

Items per page

Supplemental Content

Loading ...
Support Center